27
(2)
Components of JICA Cooperation according to the Diseases
As shown in Table 4.2, each project targeted several diseases and research on specific
diseases occurred over a period covering several projects. In consideration of this
situation, project activities were rearranged on the basis of the incidence or occurrence
of diseases.
A series of JICA technical cooperation targeted Vaccine/Vaccine Preventable Disease
(VPD), HIV/AIDS and Sexually Transmitted Diseases (STD), Diarrhoeal Diseases,
TB, and Schistosomiasis. The components of JICA
technical cooperation are
summarized below: (the activities of each project, inputs by JICA such as the dispatch
of experts, C/P training and equipment provision are described in the Annexes).
1)
Vaccines/VPD
In Ghana, a full-scale vaccination program was started in 1976, although the low
vaccination rate and the deterioration in vaccine quality became a problem.
The NMIMR started activities related to the quality control of vaccines, vaccine
potency
testing for polio, measles and yellow fever, and the effectiveness of cold
chains for vaccines from 1986. In addition, clinical trials of the heat stable Acellular
Pertussis Diphtheria Tetanus (APDT) vaccine were also carried out in three
communities in the Gomoa district from 1991.
This research was discontinued after the conclusion that the NMIMR had acquired the
necessary technology for the quality control of vaccines
at the end of the Noguchi
Memorial Institute for Medical Research Project Phase II in 1997. Then new
research on serologic testing to examine viral hemorrhagic fever was started from
1999.
2)
HIV/AIDS
・
STD
Forty-two AIDS patients were reported for the first time in Ghana in 1986, and the
total number of the AIDS patients was 10,285 by 1992 with the number of
HIV-carriers estimated at 150,000. It was estimated that there was an average 3.6%
prevalence rate as a result of a sentinel survey conducted in 2003.
JICA recognises that HIV/AIDS is a critical disease, and started
to include research
activities on HIV/AIDS from 1991. Initially, the establishment of diagnostic
methods, infection routes and mother-to-child transmission (MTCT) were the primary
focus. However, JICA took the next step to establish a standardized diagnostic
method and the preparation of a manual in cooperation
with the Ministry of Health
(MOH). In addition, JICA worked to establish testing techniques for detecting
trachoma, one of the most prominent STDs in Ghana.
As JICA cooperation included research on dangerous infectious agents such as
HIV/AIDS and drug resistant TB bacteria, a high security laboratory (P3 lab) was also
established using grant aid from the Government of Japan. In
tandem with this, a
biosafety committee to manage the P3 lab in order to handle dangerous infectious
agents was established, and biosafety countermeasures were also established at the
NMIMR.